MPS backs Health Minister's withdrawal of support for Medical Innovation Bill
Post date: 02/03/2015 | Time to read article: 1 minsThe information within this article was correct at the time of publishing. Last updated 14/11/2018
MPS has long called for a full and proper review to examine what the potential barriers to innovation might be as well as solutions. We are pleased the government has listened.
Dr Pallavi Bradshaw, Medicolegal adviser at MPS said:
“MPS has been opposed to the Medical Innovation Bill from the beginning; we believe it is an unnecessary piece of legislation that has the potential to undermine safe and established routes of innovation and could damage the relationship between doctors and their patients.
“This Bill is flawed and we believe it would have created a number of adverse unintended consequences for both patients and doctors. It gives the false impression to vulnerable patients and their families that all experimental treatments would be readily available; confuses what is meant by and covered by the term medical innovation and may cause fundamental disagreements with patients and their treating doctors about ongoing care.”
For further information or to arrange an interview please contact Rajiv Pattni, Press Officer at MPS on +44 (0) 207 399 1409 or email [email protected]
